Pfizer Seeks To Toss Celebrex, Bextra Cases
Pharmaceuticals giant Pfizer Inc. has asked a judge to dismiss complaints filed in multidistrict litigation over anti-inflammatory painkillers Celebrex and Bextra on the grounds that the plaintiffs didn't claim that deceptive...To view the full article, register now.
Already a subscriber? Click here to view full article